Enhanced Oral Delivery of Curcumin from N-trimethyl Chitosan Surface-Modified Solid Lipid Nanoparticles: Pharmacokinetic and Brain Distribution Evaluations

详细信息    查看全文

• 作者：Prakash Ramalingam (1)
  Young Tag Ko (1)
  
  1. College of Pharmacy ; Gachon University ; 191 Hambakmoero ; Yeonsu-gu ; Incheon ; 406-799 ; South Korea
  
• 关键词：coating ; curcumin ; N ; trimethyl chitosan ; oral drug delivery ; solid lipid nanoparticles
• 刊名：Pharmaceutical Research
• 出版年：2015
• 出版时间：February 2015
• 年：2015
• 卷：32
• 期：2
• 页码：389-402
• 全文大小：2,561 KB
• 参考文献：1. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78(18):2081鈥?. CrossRef
  2. Tang H, Murphy CJ, Zhang B, Shen Y, Van Kirk EA, Murdoch WJ, / et al. Curcumin polymers as anticancer conjugates. Biomaterials. 2010;31(27):7139鈥?9. CrossRef
  3. Mondal G, Barui S, Saha S, Chaudhuri A. Tumor growth inhibition through targeting liposomally bound curcumin to tumor vasculature. J Control Release. 2013;172(3):832鈥?0. CrossRef
  4. Sun J, Bi C, Chan HM, Sun S, Zhang Q, Zheng Y. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Colloids Surf B: Biointerfaces. 2013;111:367鈥?5. CrossRef
  5. Mehnert W, M盲der K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2012;64:83鈥?01. CrossRef
  6. M眉ller RH, M盲der K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery鈥攁 review of the state of the art. Eur J Pharm Biopharm. 2000;50(1):161鈥?7. CrossRef
  7. Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release. 2004;95(3):627鈥?8. CrossRef
  8. Venishetty VK, Chede R, Komuravelli R, Adepu L, Sistla R, Diwan PV. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration. Colloids Surf B: Biointerfaces. 2012;95:1鈥?. CrossRef
  9. Madan J, Pandey RS, Jain V, Katare OP, Chandra R, Katyal A. Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cells. Nanomedicine Nanotechnol Biol Med. 2013;9(4):492鈥?03. CrossRef
  10. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release. 2004;100(1):5鈥?8. CrossRef
  11. Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink WE, Jiskoot W. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release. 2006;111(1鈥?):107鈥?6. CrossRef
  12. Thanou M, Verhoef JC, Junginger HE. Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev. 2001;52(2):117鈥?6. CrossRef
  13. Chen F, Zhang Z-R, Yuan F, Qin X, Wang M, Huang Y. In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery. Int J Pharm. 2008;349(1鈥?):226鈥?3. CrossRef
  14. Subbiah R, Ramalingam P, Ramasundaram S, Kim DY, Park K, Ramasamy MK, / et al. N, N, N-Trimethyl chitosan nanoparticles for controlled intranasal delivery of HBV surface antigen. Carbohydr Polym. 2012;89(4):1289鈥?7. CrossRef
  15. Jintapattanakit A, Junyaprasert VB, Mao S, Sitterberg J, Bakowsky U, Kissel T. Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles. Int J Pharm. 2007;342(1):240鈥?. CrossRef
  16. Sandri G, Rossi S, Bonferoni MC, Ferrari F, Zambito Y, Colo GD, / et al. Buccal penetration enhancement properties of <i> N</i> -trimethyl chitosan: influence of quaternization degree on absorption of a high molecular weight molecule. Int J Pharm. 2005;297(1):146鈥?5. CrossRef
  17. Di Colo G, Burgalassi S, Zambito Y, Monti D, Chetoni P. Effects of different N鈥恡rimethyl chitosans on in vitro/in vivo ofloxacin transcorneal permeation. J Pharm Sci. 2004;93(11):2851鈥?2. CrossRef
  18. Florea BI, Thanou M, Junginger HE, Borchard G. Enhancement of bronchial octreotide absorption by chitosan and <i> N</i> -trimethyl chitosan shows linear in vitro/in vivo correlation. J Control Release. 2006;110(2):353鈥?1. CrossRef
  19. He W, Du Y, Dai W, Wu Y, Zhang M. Effects of N鈥恡rimethyl chitosan chloride as an absorption enhancer on properties of insulin liquid suppository in vitro and in vivo. J Appl Polym Sci. 2006;99(3):1140鈥?. CrossRef
  20. Say谋n B, Somavarapu S, Li XW, Sesardic D, 艦enel S, Alpar OH. TMC鈥揗CC (N-trimethyl chitosan鈥搈ono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines. Eur J Pharm Sci. 2009;38(4):362鈥?. CrossRef
  21. Yin L, Ding J, He C, Cui L, Tang C, Yin C. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials. 2009;30(29):5691鈥?00. CrossRef
  22. Cafaggi S, Russo E, Stefani R, Leardi R, Caviglioli G, Parodi B, / et al. Preparation and evaluation of nanoparticles made of chitosan or <i> N</i> -trimethyl chitosan and a cisplatin鈥揳lginate complex. J Control Release. 2007;121(1):110鈥?3. CrossRef
  23. Germershaus O, Mao S, Sitterberg J, Bakowsky U, Kissel T. Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure鈥揳ctivity relationships in vitro. J Control Release. 2008;125(2):145鈥?4. CrossRef
  24. Chen H, Wu J, Sun M, Guo C, Yu A, Cao F, / et al. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin. J Liposome Res. 2012;22(2):100鈥?.
  25. Sl眉tter B, Soema PC, Ding Z, Verheul R, Hennink W, Jiskoot W. Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen. J Control Release. 2010;143(2):207鈥?4. CrossRef
  26. Zhang Z, Tan S, Feng S-S. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials. 2012;33(19):4889鈥?06. CrossRef
  27. Ramasamy TG, Haidar ZS. Formulation, characterization and cytocompatibility evaluation of novel coreshell solid lipid nanoparticles for the controlled and tunable delivery of a model protein. J Bionanoscience. 2011;5(2):143鈥?4. CrossRef
  28. Zanotto-Filho A, Coradini K, Braganhol E, Schr枚der R, de Oliveira CM, Sim玫es-Pires A, / et al. Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment. Eur J Pharm Biopharm. 2013;83(2):156鈥?7. CrossRef
  29. Mangolim CS, Moriwaki C, Nogueira AC, Sato F, Baesso ML, Neto AM, / et al. Curcumin鈥撐?cyclodextrin inclusion complex: Stability, solubility, characterisation by FT-IR, FT-Raman, X-ray diffraction and photoacoustic spectroscopy, and food application. Food Chem. 2014;153:361鈥?0. CrossRef
  30. Zhang J, Tang Q, Xu X, Li N. Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery. Int J Pharm. 2013;448(1):168鈥?4. CrossRef
  31. Kakkar V, Singh S, Singla D, Kaur IP. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res. 2011;55(3):495鈥?03. CrossRef
  32. Wohlfart S, Khalansky AS, Gelperina S, Begley D, Kreuter J. Kinetics of transport of doxorubicin bound to nanoparticles across the blood鈥揵rain barrier. J Control Release. 2011;154(1):103鈥?. CrossRef
  33. Mehnert W, M盲der K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47(2鈥?):165鈥?6. CrossRef
  34. Chen C-C, Tsai T-H, Huang Z-R, Fang J-Y. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm. 2010;74(3):474鈥?2. CrossRef
  35. Subedi RK, Kang KW, Choi H-K. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci. 2009;37(3鈥?):508鈥?3. CrossRef
  36. de Carvalho SM, Noronha CM, Floriani CL, Lino RC, Rocha G, Bellettini IC, / et al. Optimization of 伪-tocopherol loaded solid lipid nanoparticles by central composite design. Ind Crop Prod. 2013;49:278鈥?5. CrossRef
  37. Pawar YB, Shete G, Popat D, Bansal AK. Phase behavior and oral bioavailability of amorphous Curcumin. Eur J Pharm Sci. 2012;47(1):56鈥?4. CrossRef
  38. Mulik RS, M枚nkk枚nen J, Juvonen RO, Mahadik KR, Paradkar AR. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm. 2010;398(1鈥?):190鈥?03. CrossRef
  39. van der Merwe SM, Verhoef JC, Verheijden JHM, Kotz茅 AF, Junginger HE. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm. 2004;58(2):225鈥?5. CrossRef
  40. Porter CJH, Charman WN. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev. 2001;50(1鈥?):61鈥?0. CrossRef
  41. Wang ZH, Wang ZY, Sun CS, Wang CY, Jiang TY, Wang SL. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Biomaterials. 2010;31(5):908鈥?5. CrossRef
  
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Biomedicine
  Pharmacology and Toxicology
  Pharmacy
  Biochemistry
  Medical Law
  Biomedical Engineering
  
• 出版者：Springer Netherlands
• ISSN：1573-904X

文摘